KDLY Quote, Financials, Valuation and Earnings

Encompass Health has a net margin of -179.07% compared to Kindly MD's net margin of 10.41%. Kindly MD's return on equity of -188.85% beat Encompass Health's return on equity of 18.4%.

Kindly MD has a consensus price target of --, signalling downside risk potential of --. On the other hand Encompass Health has an analysts' consensus of $131.27 which suggests that it could grow by 8.48%. Given that Encompass Health has higher upside potential than Kindly MD, analysts believe Encompass Health is more attractive than Kindly MD.

Kindly MD has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Encompass Health has a beta of 0.930, suggesting its less volatile than the S&P 500 by 7.02%.

Kindly MD has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health offers a yield of 0.55% to investors and pays a quarterly dividend of $0.17 per share. Kindly MD pays -- of its earnings as a dividend. Encompass Health pays out 13.78% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Kindly MD quarterly revenues are $579.7K, which are smaller than Encompass Health quarterly revenues of $1.5B. Kindly MD's net income of -$1M is lower than Encompass Health's net income of $151.5M. Notably, Kindly MD's price-to-earnings ratio is -- while Encompass Health's PE ratio is 25.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD is 57.96x versus 2.24x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.

Pediatrix Medical Group has a net margin of -179.07% compared to Kindly MD's net margin of 4.52%. Kindly MD's return on equity of -188.85% beat Pediatrix Medical Group's return on equity of -10.7%.

Kindly MD has a consensus price target of --, signalling downside risk potential of --. On the other hand Pediatrix Medical Group has an analysts' consensus of $17.14 which suggests that it could grow by 23.78%. Given that Pediatrix Medical Group has higher upside potential than Kindly MD, analysts believe Pediatrix Medical Group is more attractive than Kindly MD.

Kindly MD has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pediatrix Medical Group has a beta of 1.263, suggesting its more volatile than the S&P 500 by 26.315%.

Kindly MD has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pediatrix Medical Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kindly MD pays -- of its earnings as a dividend. Pediatrix Medical Group pays out -- of its earnings as a dividend.

Kindly MD quarterly revenues are $579.7K, which are smaller than Pediatrix Medical Group quarterly revenues of $458.4M. Kindly MD's net income of -$1M is lower than Pediatrix Medical Group's net income of $20.7M. Notably, Kindly MD's price-to-earnings ratio is -- while Pediatrix Medical Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD is 57.96x versus 0.59x for Pediatrix Medical Group. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute has a net margin of -179.07% compared to Kindly MD's net margin of -18.76%. Kindly MD's return on equity of -188.85% beat The Oncology Institute's return on equity of -340.01%.

Kindly MD has a consensus price target of --, signalling downside risk potential of --. On the other hand The Oncology Institute has an analysts' consensus of $7.00 which suggests that it could grow by 132.56%. Given that The Oncology Institute has higher upside potential than Kindly MD, analysts believe The Oncology Institute is more attractive than Kindly MD.

Kindly MD has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Kindly MD has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kindly MD pays -- of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.

Kindly MD quarterly revenues are $579.7K, which are smaller than The Oncology Institute quarterly revenues of $104.4M. Kindly MD's net income of -$1M is higher than The Oncology Institute's net income of -$19.6M. Notably, Kindly MD's price-to-earnings ratio is -- while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD is 57.96x versus 0.57x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.

US Physical Therapy has a net margin of -179.07% compared to Kindly MD's net margin of 6.97%. Kindly MD's return on equity of -188.85% beat US Physical Therapy's return on equity of 4.62%.

Kindly MD has a consensus price target of --, signalling downside risk potential of --. On the other hand US Physical Therapy has an analysts' consensus of $106.00 which suggests that it could grow by 38.6%. Given that US Physical Therapy has higher upside potential than Kindly MD, analysts believe US Physical Therapy is more attractive than Kindly MD.

Kindly MD has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison US Physical Therapy has a beta of 1.438, suggesting its more volatile than the S&P 500 by 43.783%.

Kindly MD has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. US Physical Therapy offers a yield of 2.33% to investors and pays a quarterly dividend of $0.45 per share. Kindly MD pays -- of its earnings as a dividend. US Physical Therapy pays out 100.3% of its earnings as a dividend.

Kindly MD quarterly revenues are $579.7K, which are smaller than US Physical Therapy quarterly revenues of $183.8M. Kindly MD's net income of -$1M is lower than US Physical Therapy's net income of $12.8M. Notably, Kindly MD's price-to-earnings ratio is -- while US Physical Therapy's PE ratio is 35.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kindly MD is 57.96x versus 1.65x for US Physical Therapy. Usually stocks with elevated PS ratios are considered overvalued.